Suggestions
Michael Braxenthaler
Explorer at Hyperceptual Photography
Professional Background
Michael Braxenthaler is a distinguished expert in the field of computational biology and biochemistry, bringing an extensive background that combines scientific research with leadership roles in the pharmaceutical industry. Over the years, he has established himself as a pivotal figure in driving innovations and improving strategic alliances within the biopharmaceutical sector.
Michael began his career's foundational phase by earning a PhD in Biochemistry from Universität Tübingen, a reputable institution known for its rigorous academic standards and research output. Following his PhD, he advanced his expertise through a postdoctoral fellowship in Computational Biology at the University of Maryland Biotech Institute. This academic experience provided him with the skills necessary to navigate the intricacies of biological data, setting the stage for his successful career in informatics and research.
In the corporate realm, Michael has significantly contributed to Roche, one of the world's leading healthcare companies. His journey with Roche began as a Bioinformatics Scientist, where he was instrumental in addressing complex scientific questions and nurturing a data-driven decision-making culture. His prowess in transforming data into actionable insights led him to ascend through the ranks to become the Global Head of Strategic Alliances within Pharma Research and Early Development Informatics. Michael later served as the Global Head of Scientific Workflows, a role that emphasized his ability to streamline processes and enhance collaboration across multidisciplinary teams. His tenure at Roche showcased his dedication to advancing pharmaceutical informatics and pinpointing solutions to improve research outcomes.
Education and Achievements
Michael's educational background has played a crucial role in shaping his professional trajectory. His doctorate from Universität Tübingen is complemented with postdoctoral work in Computational Biology at the University of Maryland, institutions that groomed him for leadership in research and development.
Greatly respected in his field, Michael has served as a board member for organizations such as Pistoia Alliance, Inc. and tranSMART Foundation. His leadership as President of Pistoia Alliance underscored his commitment to enhancing collaboration within the biopharma community, fostering innovation, and improving industry standards. As Co-CEO of tranSMART Foundation, he drove initiatives that emphasized open data standards and interoperability to better facilitate data sharing among research organizations.
Furthermore, his influential position as a member of the IMI2 Strategic Governing Group Data and Knowledge Management has led to advancements in strategic data management, aiding researchers and organizations in accessing and utilizing vital information effectively. His involvement in leading groups focused on standards within the IMI eTRIKS project showcases his ongoing commitment to enhancing data standardization across Europe.
Achievements
Throughout his career, Michael has made significant contributions to multiple organizations and has achieved several notable accomplishments. His powerful blend of scientific knowledge and business acumen has made him a venerated member of the global scientific community. In addition to running successful programs and initiatives, Michael has played an essential role in guidance and mentorship for new leaders in the field.
His influence extends beyond traditional research and development roles, as evidenced by his multifaceted contributions to organizational strategy and governance in systems that focus on precision medicine, data science, and research informatics. Michael's passion for leveraging technology to drive scientific progress has encouraged him to remain at the forefront of ongoing discussions related to digital transformation within biopharmaceutical research.
In summary, Michael Braxenthaler’s vast academic background, paired with his extensive professional experience, has positioned him as a leading expert and influencer in the realm of computational biology and biopharmaceutical informatics. His commitment to scientific advancement, collaborative innovation, and strategic leadership continues to leave a lasting impact across the field. Michael remains dedicated to leveraging his skills and experiences to drive excellence in all future endeavors, impacting not just organizations, but the scientific community as a whole.